The Size of the prize: Obesity set to become a top 5 disease area in India Semaglutides LoE is unlocking one of the most significant growth opportunities in the Indian pharmaceutical market, with obesity pharmacotherapy poised to become a top 5 disease area by 2030
Also, more people achieved at least a 5% reduction in body weight with Saxenda than with Orlistat (65.7% for Saxenda vs 27.4% for Orlistat)
More relevant, microbiota profiles are related to the illness phase, severity of the condition, and with some inflammatory markers such as IL-6
The compound is real, its preclinical findings are real, and the published research is peer-reviewed and indexed
Keep lyophilized vials sealed until you are ready to begin a dosing cycle
The price of tirzepatide can vary significantly based on factors such as location, insurance coverage , dosage, and provider pricing